1. Home
  2. HOWL vs TRT Comparison

HOWL vs TRT Comparison

Compare HOWL & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.65

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Logo Trio-Tech International

TRT

Trio-Tech International

HOLD

Current Price

$4.61

Market Cap

35.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
TRT
Founded
2017
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
35.1M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
HOWL
TRT
Price
$0.65
$4.61
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
350.1K
53.4K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
$32,462,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$230.00
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$4.52
52 Week High
$2.23
$14.78

Technical Indicators

Market Signals
Indicator
HOWL
TRT
Relative Strength Index (RSI) 46.49 29.55
Support Level $0.57 N/A
Resistance Level $0.67 $5.79
Average True Range (ATR) 0.06 0.44
MACD 0.01 0.01
Stochastic Oscillator 35.61 4.12

Price Performance

Historical Comparison
HOWL
TRT

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

Share on Social Networks: